Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors
Autor: | Mary Dillhoff, Zaheer Kanji, Casper H.J. van Eijck, Megan Beems, Daniel E. Abbott, Shishir K. Maithel, Kamran Idrees, Flavio G. Rocha, Timothy M. Pawlik, Eleftherios Makris, Charlotte M. Heidsma, Paula Marincola Smith, Cliff Cho, Susan van Dieren, Ryan C. Fields, Alexandra G. Lopez-Aguiar, Elisabeth J. M. Nieveen van Dijkum, Diamantis I. Tsilimigras, George A. Poultsides, Alexander V. Fisher, Bradley A. Krasnick |
---|---|
Přispěvatelé: | Graduate School, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Surgery, APH - Methodology |
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Pancreatic neuroendocrine tumor medicine.medical_treatment Enucleation Neuroendocrine tumors Gastroenterology Pancreaticoduodenectomy Pancreatic Fistula 03 medical and health sciences Pancreatectomy Postoperative Complications 0302 clinical medicine Internal medicine medicine Humans Retrospective Studies Hepatology business.industry Incidence (epidemiology) Common procedures medicine.disease Pancreatic Neoplasms Neuroendocrine Tumors Treatment Outcome Pancreatic fistula 030220 oncology & carcinogenesis Propensity score matching 030211 gastroenterology & hepatology business |
Zdroj: | HPB: The official journal of the International Hepato Pancreato Biliary Association, 23(3), 413-421. John Wiley and Sons Inc. HPB, 23(3), 413-421. John Wiley & Sons Inc. |
ISSN: | 1365-182X |
Popis: | Background: Pancreatoduodenectomy (PD) or distal pancreatectomy (DP) are common procedures for patients with a pancreatic neuroendocrine tumor (pNET). Nevertheless, certain patients may benefit from a pancreas-preserving resection such as enucleation (EN). The aim of this study was to define the indications and differences in long-term outcomes among patients undergoing EN and PD/DP. Methods: Patients undergoing resection of a pNET between 1992 and 2016 were identified. Indications and outcomes were evaluated, and propensity score matching (PSM) analysis was performed to compare long-term outcomes between patients who underwent EN versus PD/DP. Results: Among 1034 patients, 143 (13.8%) underwent EN, 304 (29.4%) PD, and 587 (56.8%) DP. Indications for EN were small size (1.5 cm, IQR:1.0–1.9), functional tumors (58.0%) that were mainly insulinomas (51.7%). After PSM (n = 109 per group), incidence of postoperative pancreatic fistula (POPF) grade B/C was higher after EN (24.5%) compared with PD/DP (14.0%) (p = 0.049). Median recurrence-free survival (RFS) was comparable among patients who underwent EN (47 months, 95% CI:23–71) versus PD/DP (37 months, 95% CI: 33–47, p = 0.480). Conclusion: Comparable long-term outcomes were noted among patients who underwent EN versus PD/DP for pNET. The incidence of clinically significant POPF was higher after EN. |
Databáze: | OpenAIRE |
Externí odkaz: |